TickerFacts.

Company research / PDEX

PRO DEX Inc (PDEX)

Build a valuation ↗↓ Download CSV

SEC name PRO DEX INC · CIK 0000788920 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Fiscal year ends Jun 30

For the year ended 2026-06-30, PRO DEX Inc reported revenue of $77.55M. Revenue grew 16.5% from the prior annual period.

Key ratios (year ended 2026-06-30)

31.4%
Gross margin
16.8%
Operating margin
17.6%
Net margin
28.7%
Return on year-end equity
16.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form DEF 14A (proxy statement) · 2026-10-06

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2026-06-302025-06-302024-06-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-31
Revenue$77.55M$66.59M$53.84M$46.09Mn/an/an/a$42.04Mn/an/a
Cost of Revenue$53.21M$47.08M$39.29M$33.34Mn/an/an/a$28.91Mn/an/a
Gross Profit$24.34M$19.51M$14.55M$12.75Mn/an/an/a$13.13Mn/an/a
R&D Expense$3.35M$3.64M$3.19M$2.80Mn/an/an/a$2.98Mn/an/a
Operating Income$12.99M$10.69M$7.17M$5.76Mn/an/an/a$5.12Mn/an/a
Depreciation & Amortization$1.39M$1.24M$1.16M$857.0Kn/an/an/a$726.0Kn/an/a
EBITDA$14.38M$11.93M$8.33M$6.62Mn/an/an/a$5.85Mn/an/a
Net Income$13.66M$8.98M$2.13M$7.07Mn/an/an/a$4.57Mn/an/a
EPS (Diluted)$4.12$2.67$0.60$1.95n/an/an/a$1.21n/an/a
Total Assets$74.51M$61.19M$52.48M$51.82M$51.69M$51.88M$49.85M$49.09M$45.22M$43.33M
Total Liabilities$26.88M$24.56M$21.61M$20.23M$21.79M$23.64Mn/a$23.66Mn/an/a
Long-Term Debt$17.51M$15.43M$11.96M$12.80Mn/an/an/a$13.59Mn/an/a
Shareholders' Equity$47.63M$36.63M$30.87M$31.59Mn/an/an/a$25.43Mn/an/a
Cash & Equivalents$8.19M$419.0K$2.63M$2.94Mn/an/an/a$849.0Kn/an/a
Operating Cash Flow$7.24M-$1.68M$6.22M$5.46Mn/an/an/a-$847.0Kn/an/a
Capital Expenditures$483.0K$1.25Mn/an/an/an/an/a$1.64Mn/an/a
Free Cash Flow$6.76M-$2.93Mn/an/an/an/an/a-$2.48Mn/an/a
Share Repurchases$3.41M$3.50M$3.50M$1.55Mn/an/an/a$1.61Mn/an/a
Shares Outstanding3.19M3.26M3.36M3.55Mn/an/an/a3.60Mn/an/a
Weighted Average Diluted Shares3.32M3.36M3.57M3.64Mn/an/an/a3.76Mn/an/a
EPS (Basic)$4.24$2.73$0.61$1.98n/an/an/a$1.26n/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView